Companies / Germany
Boehringer Ingelheim In Good Health
April 2007 | Company Finance AlertGerman drugmaker Boehringer Ingelheim (BI) has recorded net sales of EUR10.6bn (US$14.2bn) for the 2006 financial year, an increase of 11%, while operating income grew 11% to EUR2.1bn (US$2.8bn). The privately held company, which announced its results at its annual press conference, expects sales growth in 2007 to be in the high-single digits, beating the market.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
